Recombinant Annexin A2 Administration Improves Neurological Outcomes After Traumatic Brain Injury in Mice

Microvascular failure is one of the key pathogenic factors in the dynamic pathological evolution after traumatic brain injury (TBI). Our laboratory and others previously reported that Annexin A2 functions in blood-brain barrier (BBB) development and cerebral angiogenesis, and recombinant human Annex...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, Chongjie, Wang, Xiaoshu, Jiang, Yinghua, Li, Yadan, Liao, Zhengbu, Li, Wenlu, Yu, Zhanyang, Whalen, Michael J., Lok, Josephine, Dumont, Aaron S., Liu, Ning, Wang, Xiaoying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363504/
https://www.ncbi.nlm.nih.gov/pubmed/34400908
http://dx.doi.org/10.3389/fphar.2021.708469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363504/
https://www.ncbi.nlm.nih.gov/pubmed/34400908
http://dx.doi.org/10.3389/fphar.2021.708469

Ejemplares similares